Our findings demonstrate that the SOX2-ANRIL-β-catenin axis plays a critical role in nasopharyngeal carcinoma proliferation and provide a potential therapeutic approach for nasopharyngeal carcinoma patients. This evidence concerns the gene CDKN2B-AS1 and nasopharyngeal carcinoma.